The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the successful reclassification of Nasonex Allergy Control 0.05% Nasal Spray following a public consultation. The spray, which will soon be available over the counter in pharmacies, is used to treat symptoms of allergic rhinitis. 

The decision follows the POM to P reclassification granted to Maloff Protect last week. MHRA commented that is “committed to involving people in their healthcare, and to widen access to medicines for the benefit of public health when it is safe to do”.


SMEs looking to spend more on marketing in 2018/19

Many small businesses are looking to up their marketing spend in the next financial year, with the average SME plan...

Don’t miss nomination deadline, NPA urges

The NPA has issued a call for members to nominate a candidate for the forthcoming board of management elections by ...